Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Reprod Fertil Dev ; 28(6): 682-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25483008

RESUMO

We have previously shown the influence of leukotrienes (LTs) on reproductive functions in vivo: LTB4 is luteotrophic and supports corpus luteum function inducing PGE2 and progesterone (P4) secretion, whereas LTC4 is luteolytic and stimulates PGF2α secretion in cattle. The aim of this study was to examine expression and production profiles of LTs and their actions in the endometrium. LT receptors (LTB4R for LTB4 and CysLTR2 for LTC4), 5-lipoxygenase (LO), 12-LO synthase (LTCS) and LTA4 hydrolase (LTAH) mRNA and protein expression, as well as LT production were measured in bovine endometrial tissue during the luteal phases of the oestrous cycle. The action of LTs on uterine function was studied by measuring the level of PGs after stimulating uterine slices with LTs on Days 8-10 of the cycle. Expression of 5-LO and LTB4R mRNA and protein were highest on Days 2-4 of the cycle, while CysLTR2 and LTCS were highest on Days 16-18 (P<0.05). LTB4 concentration was highest on Days 2-4 of the cycle, whereas the greatest LTC4 level was on Days 16-18 (P<0.05). Both LTB4 and C4 increased the content of PGE2 and F2α in endometrial slices at a dose of 10(-7)M (P<0.05). In summary, mRNA expression and activation of receptors for LTB4 and production occur in the first part of the cycle, whereas LTC4 and its receptors predominate at the end of the cycle. The 12-LO and 5-LO pathways are complementary routes of LT production in the bovine uterus.


Assuntos
Araquidonato 5-Lipoxigenase/metabolismo , Endométrio/metabolismo , Glutationa Transferase/metabolismo , Leucotrienos/metabolismo , Fase Luteal/metabolismo , Receptores do Leucotrieno B4/metabolismo , Receptores de Leucotrienos/metabolismo , Matadouros , Animais , Animais Endogâmicos , Araquidonato 5-Lipoxigenase/genética , Bovinos , Indústria de Laticínios , Endométrio/enzimologia , Ciclo Estral/metabolismo , Feminino , Perfilação da Expressão Gênica/veterinária , Regulação Enzimológica da Expressão Gênica , Glutationa Transferase/genética , Leucotrieno B4/metabolismo , Leucotrieno C4/metabolismo , Polônia , Prostaglandinas/agonistas , Prostaglandinas/metabolismo , RNA Mensageiro/metabolismo , Receptores de Leucotrienos/agonistas , Receptores de Leucotrienos/genética , Receptores do Leucotrieno B4/agonistas , Receptores do Leucotrieno B4/genética , Técnicas de Cultura de Tecidos/veterinária
2.
Eur J Pharmacol ; 754: 98-104, 2015 May 05.
Artigo em Inglês | MEDLINE | ID: mdl-25704617

RESUMO

Cysteinyl leukotrienes act through G-protein-coupled receptors termed cysteinyl leukotriene 1 (CysLT1) and cysteinyl leukotriene 2 (CysLT2) receptors. However, little is known about the pathophysiological role of CysLT2 receptors in asthma. To elucidate the possible involvement of CysLT2 receptors in bronchoconstriction and airway vascular hyperpermeability, we have established a novel guinea pig model of asthma. In vitro study confirmed that CHO-K1 cells, expressing guinea pig CysLT2 and CysLT1 receptors are selectively stimulated by LTC4 and LTD4, respectively. However, when LTC4 was intravenously injected to guinea pigs, the resulting bronchoconstriction was fully abrogated by montelukast, a CysLT1 receptor antagonist, indicating rapid metabolism of LTC4 to LTD4 in the lung. We found that treatment with S-hexyl glutathione (S-hexyl GSH), an inhibitor of gamma-glutamyl transpeptidase, significantly increased LTC4 content and LTC4/(LTD4 plus LTE4) ratio in the lung. Under these circumstances, LTC4-induced bronchoconstriction became resistant to montelukast, but sensitive to Compound A, a CysLT2 receptor antagonist, depending on the dose of S-hexyl GSH. Combination with montelukast and Compound A completely abrogated this spasmogenic response. Additionally, we confirmed that LTC4 elicits airway vascular hyperpermeability via CysLT2 receptors in the presence of high dose of S-hexyl GSH as evidenced by complete inhibition of LTC4-induced hyperpermeability by Compound A, but not montelukast. These results suggest that CysLT2 receptors mediate bronchoconstriction and airway vascular hyperpermeability in guinea pigs and that the animal model used in this study may be useful to elucidate the functional role of CysLT2 receptors in various diseases, including asthma.


Assuntos
Broncoconstrição/efeitos dos fármacos , Permeabilidade Capilar/efeitos dos fármacos , Glutationa/análogos & derivados , Leucotrieno C4/farmacologia , Receptores de Leucotrienos/fisiologia , Acetatos/farmacologia , Animais , Broncoconstrição/fisiologia , Cálcio/farmacologia , Permeabilidade Capilar/fisiologia , Ciclopropanos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Glutationa/farmacologia , Cobaias , Leucotrieno C4/antagonistas & inibidores , Leucotrieno C4/farmacocinética , Leucotrieno D4/farmacologia , Pulmão/metabolismo , Masculino , Quinolinas/farmacologia , Receptores de Leucotrienos/agonistas , Receptores de Leucotrienos/efeitos dos fármacos , Sulfetos , Triazóis/farmacologia
3.
Blood ; 119(13): 3113-22, 2012 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-22323449

RESUMO

Generation of human monocyte-derived dendritic cells (DCs) for cancer vaccination involves ex vivo maturation in the presence of proinflammatory cytokines and prostaglandin E(2) (PGE(2)). Although the inclusion of PGE(2) during maturation is imperative for the induction of DC migration, PGE(2) has unfavorable effects on the immunostimulatory capacity of these cells. Like PGE(2), leukotrienes (LTs) are potent mediators of DC migration. We therefore sought to characterize the migratory and immunologic properties of DCs that matured in the presence of LTB(4), LTC(4), LTD(4), and PGE(2). Here, we demonstrate that DCs matured in the presence of LTC(4), but not LTB(4) or LTD(4), are superior to PGE(2)-matured DCs in stimulating CD4(+) T-cell responses and in inducing antigen-specific cytotoxic T lymphocytes (CTLs) in vitro without concomitant induction or recruitment of regulatory T cells (Tregs). LTC(4)-matured DCs migrate efficiently through layers of extracellular matrix and secrete higher levels of immunostimulatory IL-12p70 while producing reduced levels of immune-inhibitory IL-10, IL12p40, indoleamine-2,3-dioxidase, and TIMP-1 (tissue inhibitor of matrix metalloproteinases). Intracellular calcium mobilization and receptor antagonist studies reveal that, in contrast to LTD(4), LTC(4) did not signal through CysLTR(1) in DCs. Collectively, our data suggest that LTC(4) represents a promising candidate to replace PGE(2) in DC maturation protocols for cancer vaccination.


Assuntos
Movimento Celular/efeitos dos fármacos , Células Dendríticas/efeitos dos fármacos , Leucotrieno C4/farmacologia , Ativação Linfocitária/efeitos dos fármacos , Antígenos de Neoplasias/imunologia , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/imunologia , Células Cultivadas , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , Células Dendríticas/fisiologia , Avaliação Pré-Clínica de Medicamentos , Humanos , Leucotrieno C4/metabolismo , Leucotrieno D4/metabolismo , Leucotrieno D4/fisiologia , Ativação Linfocitária/imunologia , Monócitos/efeitos dos fármacos , Monócitos/imunologia , Monócitos/metabolismo , Monócitos/fisiologia , Receptores de Leucotrienos/agonistas , Receptores de Leucotrienos/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/imunologia , Linfócitos T Citotóxicos/efeitos dos fármacos , Linfócitos T Citotóxicos/imunologia , Regulação para Cima/efeitos dos fármacos
4.
Biochim Biophys Acta ; 1660(1-2): 75-9, 2004 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-14757222

RESUMO

Addition of LTD4 (10 nM) to Xenopus laevis oocytes expressing the mCysLT1 receptor together with hBK or hIK channels resulted in the activation of both channels secondary to an LTD4-induced increase in [Ca2+]i. In addition, the hIK channel is activated by low concentrations of LTD4 (<0.1 nM), which did not result in any increase in [Ca2+]i. Even though activation of hIK by low concentrations of LTD4 was independent of an increase in [Ca2+]i, a certain "permissive" level of [Ca2+]i was required for its activation, since buffering of intracellular Ca2+ by EGTA completely abolished the response to LTD4. Neither hTBAK1 nor hTASK2 was activated following stimulations with LTD4 (0.1 and 100 nM).


Assuntos
Citocinas/biossíntese , Proteínas de Membrana/biossíntese , Oócitos/metabolismo , Canais de Potássio de Domínios Poros em Tandem , Receptores de Leucotrienos/biossíntese , Animais , Cálcio/análise , Cálcio/metabolismo , Cátions Bivalentes , Linhagem Celular/efeitos dos fármacos , Citocinas/genética , Ácido Egtázico , Humanos , Concentração de Íons de Hidrogênio , Canais de Potássio Ativados por Cálcio de Condutância Alta , Leucotrieno D4/antagonistas & inibidores , Leucotrieno D4/farmacologia , Proteínas de Membrana/agonistas , Proteínas de Membrana/genética , Oócitos/efeitos dos fármacos , Canais de Potássio/análise , Canais de Potássio Cálcio-Ativados/biossíntese , Canais de Potássio Cálcio-Ativados/genética , RNA Complementar/farmacologia , Receptores de Leucotrienos/agonistas , Receptores de Leucotrienos/genética , Transfecção , Xenopus laevis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA